Model Number 305 |
Device Problem
Calcified (1077)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 10/31/2014 |
Event Type
Injury
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic¿s quality laboratory, the non-coronary and left cusps were stiff due to host tissue on the outflow.The right cusp was slightly stiff but flexible.Tears on the tunica of all leaflets appeared to be due to the removal of host tissue during explant.All commissures were intact.Traces of pannus remained attached along the sewing ring on the inflow.A large remnant of glistening off white pannus remained attached to the sewing ring on the outflow adjacent to the left right stent post.Tan thrombotic appearing host tissue filled and stiffened the non-coronary and left cusps on the outflow.Traces of tan thrombotic appearing host tissue lined the right cusp on the outflow.Radiography showed no evidence of mineralization in the valve and/or host tissue.
|
|
Manufacturer Narrative
|
Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The transesophageal echocardiogram (tee) reports provided for medtronic over-read were limited in quantity and quality, with poor visualization of the bioprosthesis.A summary result of the echo over-read states that the bioprosthesis leaflets were not well visualized, but as shown they were normal, with no calcification evident on the available images.There was no aortic regurgitation.Based on the product analysis and echocardiogram over-read, the reported calcification and the reason for the explant cannot be confirmed.The observed thrombus that filled the cusps on the outflow could cause the immobile leaflets and compromised forward flow.Based on received communication, the patient does not have any past medical history of having blood disorders.A conclusive cause of the thrombus cannot be determined.Medtronic will continue to monitor field performance for similar events should they occur.
|
|
Event Description
|
Medtronic received information that calcification of this bioprosthetic aortic valve was observed six months after its implant.Subsequently, the valve was explanted and replaced with another manufacturer¿s device.No subsequent adverse patient effects were reported.
|
|
Manufacturer Narrative
|
It was reported that the device and a cine copy of the procedure will be returned for analysis.A supplemental report will be filed when the analysis/investigation is completed.(b)(4).
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|